Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Marcus Clarin"'
Autor:
Else Huyck, Manu Vandijck, Andrea I Benet, Ondrej Lerch, Serge Gauthier, Martin Vyhnalek, Jakub Hort, Katerina Sheardova, Marcel M. Verbeek, Lucilla Parnetti, Alberto Lleó, Daniel Alcolea, Mira Chamoun, Jenna Stevenson, Nicholas J. Ashton, Tharick A. Pascoal, Katerina Cechova, Roberta Rinaldi, Pedro Rosa-Neto, Kaj Blennow, Samuela Cataldi, Ulf Andreasson, Johan Gobom, Giovanni Bellomo, Henrik Zetterberg, Jan Laczó, Neserine Rahmouni, Nathalie Le Bastard, Marcus Clarin
Publikováno v:
Clinical Chemistry and Laboratory Medicine, 60, 207-219
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Clinical Chemistry and Laboratory Medicine, 60, 2, pp. 207-219
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Clinical Chemistry and Laboratory Medicine, 60, 2, pp. 207-219
Objectives The core cerebrospinal fluid (CSF) biomarkers; total tau (tTau), phospho-tau (pTau), amyloid β 1-42 (Aβ 1-42), and the Aβ 1-42/Aβ 1-40 ratio have transformed Alzheimer’s disease (AD) research and are today increasingly used in clinic
Autor:
Eric Peter Thelin, Nicholas C. Cullen, Karolina Minta, Ulf Andreasson, Faiez Al Nimer, Henrik Zetterberg, Marcus Clarin, Mats Tullberg, Kaj Blennow, Erik Portelius, Anna Jeppsson, Fredrik Piehl
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 57:1565-1573
Background Brevican, neurocan, tenascin-C and tenascin-R are extracellular matrix proteins present in brain that show increased expression in experimental animal models of brain injury. However, little is known about the dynamics of these proteins in
Autor:
Nathalie Le Bastard, Marcus Clarin, Ulf Andreasson, Henrik Zetterberg, Manu Vandijck, Kaj Blennow, Johan Gobom, Els Huyck
Publikováno v:
Alzheimer's & Dementia. 15:P341-P342
Autor:
Petronella Kettunen, Erik Portelius, Petra Bergström, Kaj Blennow, Henrik Zetterberg, Gunnar Brinkmalm, Lotta Agholme, Marcus Clarin, Eleni Gkanatsiou
Publikováno v:
Alzheimer's & Dementia. 13
Autor:
Henrik Zetterberg, Kaj Blennow, Petronella Kettunen, Lotta Agholme, Eleni Gkanatsiou, Erik Portelius, Marcus Clarin, Petra Bergström, Jasmine Chebli, Gunnar Brinkmalm
Publikováno v:
Molecular and Cellular Neuroscience
γ-Secretase inhibitors have been considered promising drug candidates against Alzheimer's disease (AD) due to their ability to reduce amyloid-β (Aβ) production. However, clinical trials have been halted due to lack of clinical efficacy and/or side